Brief: Seelos Therapeutics, Inc. Announces $4.0 Million Registered Direct Offering And Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules
26/01/2024 17:10
Jan 26 (Reuters) - Seelos Therapeutics Inc SEEL.O :
* SEELOS THERAPEUTICS, INC. ANNOUNCES $4.0 MILLION
REGISTERED
DIRECT OFFERING AND CONCURRENT PRIVATE PLACEMENT PRICED
AT-THE-MARKET UNDER NASDAQ RULES
* SEELOS THERAPEUTICS INC - COMBINED PURCHASE PRICE OF
$1.175 PER
SHARE
Source text for Eikon: ID:nPn8yNRW7a
Further company coverage: SEEL.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Seelos Therapeutics
See all newsBrief: Seelos Therapeutics Commences Chapter 11 Proceedings- Court Filing
Brief: Seelos Therapeutics Announces Notice Of Delisting From Nasdaq And Transfer Of Listing To Over-The-Counter Market
Brief: Seelos Announces Postponement Of Its Annual Meeting Of Stockholders
Brief: Seelos Therapeutics Announces 1-For-16 Reverse Stock Split
U.S. STOCKS ON THE MOVE-Copper miners, Visa, Bluebird bio